Security key
000899104
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 238,388,839
- Total 13F shares
- 25,531,842
- Share change
- +9,182,039
- Total reported value
- $115,150,787
- Price per share
- $4.51
- Number of holders
- 53
- Value change
- +$41,337,517
- Number of buys
- 47
- Number of sells
- 11
Report period
Q2 2018
Institutions
53
Top holders
10
ADMA full security history
Newer quarter: Q3 2018
Previous quarter: Q1 2018
ADMA BIOLOGICS, INC. SEC filings
ADMA BIOLOGICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 000899104
Recent filing periods:
Top shareholders of ADMA - ADMA BIOLOGICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.6%
|
3,821,102
|
$17,577,000 | — | 31 Mar 2018 | |
| Aisling Capital LLC |
13F
|
Company |
1.5%
|
3,608,171
|
$16,598,000 | — | 31 Mar 2018 | |
| Consonance Capital Management LP |
13F
|
Company |
1.4%
|
3,329,234
|
$15,314,000 | — | 31 Mar 2018 | |
| Biomark Capital Management Co. LLC |
13F
|
Company |
0.6%
|
1,433,304
|
$6,593,000 | — | 31 Mar 2018 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.37%
|
886,987
|
$4,080,000 | — | 31 Mar 2018 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.34%
|
805,000
|
$3,703,000 | — | 31 Mar 2018 | |
| Broadfin Capital, LLC |
13F
|
Company |
0.3%
|
720,529
|
$3,314,000 | — | 31 Mar 2018 | |
| Iguana Healthcare Management, LLC |
13F
|
Company |
0.25%
|
600,000
|
$2,760,000 | — | 31 Mar 2018 | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.13%
|
312,500
|
$1,438,000 | — | 31 Mar 2018 | |
| MORGENS WATERFALL VINTIADIS & CO INC |
13F
|
Company |
0.13%
|
300,000
|
$1,380,000 | — | 31 Mar 2018 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.11%
|
273,621
|
$1,259,000 | — | 31 Mar 2018 | |
| FMR LLC |
13F
|
Company |
0.09%
|
218,743
|
$1,006,000 | — | 31 Mar 2018 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
112,000
|
$515,000 | — | 31 Mar 2018 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.04%
|
94,476
|
$435,000 | — | 31 Mar 2018 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.04%
|
93,294
|
$429,000 | — | 31 Mar 2018 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
57,300
|
$264,000 | — | 31 Mar 2018 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.02%
|
40,536
|
$186,000 | — | 31 Mar 2018 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
39,491
|
$182,000 | — | 31 Mar 2018 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
29,143
|
$134,000 | — | 31 Mar 2018 | |
| ELEMENT CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.01%
|
25,663
|
$118,000 | — | 31 Mar 2018 | |
| BlueCrest Capital Management Ltd |
13F
|
Company |
0.01%
|
23,568
|
$108,000 | — | 31 Mar 2018 | |
| Spark Investment Management LLC |
13F
|
Company |
0.01%
|
22,200
|
$102,000 | — | 31 Mar 2018 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.01%
|
19,037
|
$87,000 | — | 31 Mar 2018 | |
| Jefferies Group LLC |
13F
|
Company |
0.01%
|
18,900
|
$87,000 | — | 31 Mar 2018 | |
| Sigma Planning Corp |
13F
|
Company |
0.01%
|
18,730
|
$86,000 | — | 31 Mar 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
13,011
|
$59,000 | — | 31 Mar 2018 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.01%
|
12,890
|
$59,000 | — | 31 Mar 2018 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
8,500
|
$39,000 | — | 31 Mar 2018 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
5,188
|
$24,000 | — | 31 Mar 2018 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
4,000
|
$19,000 | — | 31 Mar 2018 | |
| UBS Group AG |
13F
|
Company |
0%
|
3,073
|
$14,000 | — | 31 Mar 2018 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
2,900
|
$13,000 | — | 31 Mar 2018 | |
| Advisory Services Network, LLC |
13F
|
Company |
0%
|
1,700
|
$8,000 | — | 31 Mar 2018 | |
| Wealthcare Advisory Partners LLC |
13F
|
Company |
0%
|
200
|
$1,000 | — | 31 Mar 2018 |
Institutional Holders of ADMA BIOLOGICS, INC. - Common Stock (ADMA) as of Q2 2018
As of 30 Jun 2018,
ADMA BIOLOGICS, INC. - Common Stock (ADMA) was held by
53 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,531,842 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Consonance Capital Management LP, Aisling Capital LLC, Broadfin Capital, LLC, Biomark Capital Management Co. LLC, VANGUARD GROUP INC, BlackRock Inc., 683 Capital Management, LLC, Stonepine Capital Management, LLC, and MORGENS WATERFALL VINTIADIS & CO INC.
This page lists
53
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2018 vs Q1 2018 Across Filers
Q1 2018 holders
34
Q2 2018 holders
53
Holder diff
19
| Investor | Q1 2018 Shares | Q2 2018 Shares | Share Diff | Share Chg % | Q1 2018 Value $ | Q2 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.